SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,680.00    30.00 (0.53%)
Bid:
5,670.00
Ask:
5,680.00
Spread: 10.00 (0.176%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
3rd Jun 20263:37 pmRNSDirector/PDMR Shareholding
1st Jun 20268:41 amRNSTotal Voting Rights
26th May 202610:27 amRNSDirector/PDMR Shareholding
22nd May 20263:39 pmRNSDirector/PDMR Shareholding
21st May 20263:27 pmRNSDirectors Dealing
19th May 20267:00 amRNSPreliminary Results
13th May 202611:03 amRNSIssue of Equity/Admission to Trading
1st May 202611:53 amRNSTotal Voting Rights
22nd Apr 20266:05 pmRNSDirector/PDMR Shareholding
1st Apr 20263:44 pmRNSTotal Voting Rights
31st Mar 202612:33 pmRNSIssue of Equity/Admission to Trading
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
23rd Mar 202610:31 amRNSDirector/PDMR Shareholding
12th Mar 202612:07 pmRNSHolding(s) in Company
10th Mar 20264:47 pmRNSHolding(s) in Company
4th Mar 20265:17 pmRNSHolding(s) in Company
2nd Mar 20263:24 pmRNSHolding(s) in Company
2nd Mar 20263:21 pmRNSTotal Voting Rights
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:18 pmRNSDirector/PDMR Shareholding
26th Feb 20263:55 pmRNSHolding(s) in Company
24th Feb 202611:31 amRNSDirector/PDMR Shareholding
18th Feb 20265:55 pmRNSHolding(s) in Company
18th Feb 202612:11 pmRNSHolding(s) in Company
2nd Feb 20263:54 pmRNSTotal Voting Rights
30th Jan 20266:10 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSHolding(s) in Company
28th Jan 20265:59 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSThird quarter trading statement
23rd Jan 202611:27 amRNSDirector/PDMR Shareholding
22nd Jan 20264:51 pmRNSHolding(s) in Company
22nd Jan 20263:17 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202610:52 amRNSTotal Voting Rights
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20259:15 amRNSHolding(s) in Company
1st Dec 202510:49 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.